MTOR and cancer: Currently, systemic MTOR inhibitors are used clinically to treat conditions with augmented MTOR signaling, from preventing organ transplant rejection to treating viral infection and cancer; however, this study underscores the importance of protecting vascular integrity in MTOR-inhibited conditions (61, 62, 63, 64, 65).